-
Story
Marc’s story: Raising awareness of elevated Lp(a) in cardiovascular disease -
Story
Giving voice to people with a misunderstood disease -
Story
Facing the fear of breast cancer recurrence -
Story
Shoulder to shoulder -
Story
Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder -
Story
When you think of the word ‘cancer’, what are the first words that spring to mind? -
Press Release
Novartis Entresto® granted expanded indication in chronic heart failure by FDA
-
Story
Breaking down barriers for patients with sickle cell disease -
Featured News
Sound Up for Lung Cancer
-
Press Release
AveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1
-
Press Release
REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy
-
Press Release
AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy